What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary areas of study are Apoptosis, Cell biology, Immunology, Cancer research and Programmed cell death.
His Apoptosis research is multidisciplinary, incorporating perspectives in Cancer cell, Molecular biology and Topoisomerase-II Inhibitor.
His Cell biology research includes themes of Cell cycle, Biochemistry and Death-inducing signaling complex.
Immunology and Mutation are frequently intertwined in his study.
His work carried out in the field of Cancer research brings together such families of science as Cytotoxic T cell, Leukemia and Ex vivo.
His study focuses on the intersection of Programmed cell death and fields such as Heat shock protein with connections in the field of Signal transduction and Protein folding.
His most cited work include:
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients (934 citations)
- Hsp27 negatively regulates cell death by interacting with cytochrome c (848 citations)
- CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative (765 citations)
What are the main themes of his work throughout his whole career to date?
Eric Solary mainly focuses on Cancer research, Immunology, Cell biology, Molecular biology and Internal medicine.
His study in Cancer research is interdisciplinary in nature, drawing from both Mutation, Cytotoxic T cell, Haematopoiesis and Cancer.
His studies deal with areas such as Cancer cell and Gene as well as Immunology.
His research integrates issues of Apoptosis, Programmed cell death and Cellular differentiation in his study of Cell biology.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.
In his research, Myelodysplastic syndromes and Pathology is intimately related to Leukemia, which falls under the overarching field of Chronic myelomonocytic leukemia.
He most often published in these fields:
- Cancer research (35.86%)
- Immunology (31.12%)
- Cell biology (27.17%)
What were the highlights of his more recent work (between 2015-2021)?
- Chronic myelomonocytic leukemia (24.49%)
- Internal medicine (26.07%)
- Immunology (31.12%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Chronic myelomonocytic leukemia, Internal medicine, Immunology, Cancer research and Oncology.
His Chronic myelomonocytic leukemia study incorporates themes from Myeloid, Monocytosis, Monocyte, Leukemia and Flow cytometry.
As a part of the same scientific family, he mostly works in the field of Myeloid, focusing on White blood cell and, on occasion, Leukemoid reaction.
His Immunology research incorporates elements of Hematopoietic stem cell transplantation and Cell biology.
The various areas that Eric Solary examines in his Cell biology study include Apoptosis, Receptor, Inflammasome and Cellular differentiation.
He studied Cancer research and Cancer that intersect with DNA sequencing.
Between 2015 and 2021, his most popular works were:
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. (164 citations)
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. (164 citations)
- Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents (130 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Eric Solary spends much of his time researching Immunology, Chronic myelomonocytic leukemia, Cell biology, Leukemia and Cancer research.
He interconnects Clinical trial, Hsp90 inhibitor, Intensive care, Stem cell niche and Graft-versus-host disease in the investigation of issues within Immunology.
The Cell biology study combines topics in areas such as Chromatin, microRNA and Cellular differentiation.
His studies deal with areas such as Complex Karyotype, Founder effect, Gene, DNA repair and Familial predisposition as well as Leukemia.
His research in Cancer research intersects with topics in CD34, Tyrosine kinase, Drug resistance and Tyrosine-kinase inhibitor.
His Signal transduction research incorporates elements of Apoptosis and Kinase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
